Cara Therapeutics Inc

CARA

Sector
Healthcare

Industry
Biotechnology




Buy / Sell (dollars)

1 Month

23.3% 23.3% Complete (success)
76.7% 76.7% Complete (danger)
$225,536.46
avg. $225,536.46
$744,474.03
avg. $744,474.03

Buy/Sell Ratio

0.303

Transactions

6

Filers

4

3 Month

13.9% 13.9% Complete (success)
86.1% 86.1% Complete (danger)
$225,536.46
avg. $75,178.82
$1.392M
avg. $463,898.76

Buy/Sell Ratio

0.162

Transactions

14

Filers

4

12 Month

12.3% 12.3% Complete (success)
87.7% 87.7% Complete (danger)
$555,586.98
avg. $46,298.92
$3.958M
avg. $329,821.78

Buy/Sell Ratio

0.14

Transactions

31

Filers

8

24 Month

45.8% 45.8% Complete (success)
54.2% 54.2% Complete (danger)
$9.802M
avg. $408,428.62
$11.589M
avg. $482,863.96

Buy/Sell Ratio

0.846

Transactions

46

Filers

13

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers